VAERS Explorer
Back to explore

Report #2872864

Received Nov 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Oct 31, 2025
Onset
Nov 3, 2025
Days to onset
3
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Rash

Symptom narrative

Rash; This non-serious case was reported by a consumer and described the occurrence of rash in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included valaciclovir hydrochloride (Valacyclovir). On 31-OCT-2025, the patient received Shingrix. On 03-NOV-2025, 3 days after receiving Shingrix, the patient experienced rash (Verbatim: Rash). The outcome of the rash was resolving. It was unknown if the reporter considered the rash to be related to Shingrix. It was unknown if the company considered the rash to be related to Shingrix. Additional Information: GSK receipt Date: 06-NOV-2025 Patient had rash.

Other medications

VALACYCLOVIR